Kamada (KMDA) Change in Account Payables (2012 - 2026)
Kamada's (KMDA) quarterly Change in Account Payables came in at -$1.4 million in Q1 2026, up 61.42% YoY from -$895803.0 in Q1 2025, and up 57.13% on a QoQ basis from -$3.4 million in Q4 2025.
Kamada (KMDA) Change in Account Payables (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 15 years of Change in Account Payables data on file, last reported at -$1.4 million in Q1 2026.
- Quarterly Change in Account Payables rose 61.42% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.6 million (down 172.94% YoY) and the FY2025 annual result came in at -$6.9 million, down 660.36% from the prior year.
- Change in Account Payables advanced to -$1.4 million in Q1 2026, from -$3.4 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $12.0 million in Q4 2024 to a low of -$13.6 million in Q1 2022.
- A 5-year average of -$905753.8 and a median of -$6712.0 in 2023 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables surged 985417.24% — and 2024, when it plunged 130784.98%.
- Tracing KMDA's Change in Account Payables over 5 years: stood at $1160.0 in 2022, then surged by 985417.24% to $11.4 million in 2023, then increased by 4.73% to $12.0 million in 2024, then tumbled by 128.17% to -$3.4 million in 2025, then soared by 57.13% to -$1.4 million in 2026.
- The last three Change in Account Payables figures came in at -$1.4 million (Q1 2026), -$3.4 million (Q4 2025), and $634000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | -53.00 Mn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | -143.74 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -21.20 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Kamada | 457.71 Mn | 428.24 Mn | 22.47 Mn | 5.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.36 Mn |
| Jun 30, 2026 | 5.36 Mn |
| Mar 31, 2026 | -1.45 Mn |
| Mar 31, 2026 | -1.45 Mn |
| Dec 31, 2025 | -3.37 Mn |
| Dec 31, 2025 | -3.37 Mn |
| Sep 30, 2025 | 634,000.00 |
| Sep 30, 2025 | 634,000.00 |
| Jun 30, 2025 | -383,000.00 |
| Jun 30, 2025 | -383,000.00 |
| Mar 31, 2025 | -3.75 Mn |
| Mar 31, 2025 | -3.75 Mn |
| Dec 31, 2024 | 11.97 Mn |
| Dec 31, 2024 | 11.97 Mn |
| Sep 30, 2024 | -5.66 Mn |
| Sep 30, 2024 | -5.66 Mn |
| Jun 30, 2024 | 3.69 Mn |
| Jun 30, 2024 | 3.69 Mn |
| Mar 31, 2024 | -8.79 Mn |
| Mar 31, 2024 | -8.79 Mn |